Avalus Bioprosthesis Model 400
PMA P170006
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP170006 | Date31 Jul 2017 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Full name
- Avalus
- Trade name
- Avalus(Tm) Bioprosthesis
- Generic name
- heart-valve, non-allograft tissue
- PMA number
- FDA product code
- LWR
- Device class
- Class III
- Advisory committee
- Cardiovascular
- FDA decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
The Avalus Bioprosthesis, Model 400, is a non-allograft tissue heart valve designed for surgical implantation. It is indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic aortic valves.
This device is manufactured by Medtronic, Inc. and has received FDA PMA approval. It is intended for use in cardiovascular procedures to restore proper valve function in patients requiring aortic valve replacement.
Other devices from Medtronic, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the Avalus Bioprosthesis used for?
The Avalus Bioprosthesis is indicated for the replacement of native or prosthetic aortic valves that are diseased, damaged, or malfunctioning.
Who manufactures the Avalus Bioprosthesis?
The Avalus Bioprosthesis is manufactured by Medtronic, Inc., based in Santa Ana, California.
Has the Avalus Bioprosthesis received regulatory approval?
Yes, the Avalus Bioprosthesis, Model 400, has received FDA PMA approval under the docket number 17M-4756.